# Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms

> **NCT00468936** · PHASE3 · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 100 (estimated)

## Conditions studied

- Heart Transplant Patients

## Interventions

- **DRUG:** Myfortic

## Key facts

- **NCT ID:** NCT00468936
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-05
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2008-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00468936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00468936, "Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00468936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*